Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk and risk assessment for breast cancer: molecular and clinical aspects.

Maturitas - 20 May 2007

Beckmann M W, Bani M R, Fasching P A, Strick R, Lux M P

Abstract excerpt

Chemoprevention, prophylactic surgery and intensified screening programs are options which can be offered the patients with an increased lifetime risk (p(life)) for breast cancer (BC). Estimation of p(life) includes BRCA mutation analysis and risk estimation based on individual risk factors and family history. MENDEL and BRCAPRO are models which can estimate mutation carrier status probability (p(mut)), p(life)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Breast Neoplasms
Share to Chemoprevention

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genetic Counseling

Share to Gonadal Steroid Hormones

Share to Models, Biological

Share to Risk Assessment

Source

Identifiers

PMID: 17386982
DOI: 10.1016/j.maturitas.2007.02.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk and risk assessment for breast cancer: molecular and clinical aspects.PMID 17386982Read ↗

Evaluation of mathematical models for breast cancer risk assessment in routine clinical use.Semantic proximity Read ↗

Epidemiological models for breast cancer risk estimation.Semantic proximity Read ↗

Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?Semantic proximity Read ↗

Establishing a family risk assessment clinic for breast cancer.Semantic proximity Read ↗

[Models for risk assessment and prediction in breast cancer].Semantic proximity Read ↗

[Breast cancer: assessment of individual risk and possibilities for prevention].Semantic proximity Read ↗

Recent developments in the ability to predict and modify breast cancer risk.Semantic proximity Read ↗

Evaluating breast cancer risk: available models to assess individual breast cancer risk and probability to be a BRCA mutation carrier.Semantic proximity Read ↗

Management of the BRCA mutation carrier or high-risk patient.Semantic proximity Read ↗

Understanding mathematical models for breast cancer risk assessment and counseling.Semantic proximity Read ↗

[Risk assessment in familial breast cancer].Semantic proximity Read ↗

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.